Purine toxicity in human lymphoblasts.
D000225:Adenine / Q000031:analogs & derivatives / Q000494:pharmacology; D000228:Adenine Phosphoribosyltransferase / Q000172:deficiency; D000241:Adenosine / Q000633:toxicity*; D058892:Adenosine Deaminase Inhibitors; D000248:Adenosine Kinase / Q000172:deficiency; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D004357:Drug Synergism; D005947:Glucose / Q000378:metabolism; D007042:Hypoxanthines / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects*; D009154:Mutation; D010754:Phosphoribosyl Pyrophosphate / Q000378:metabolism; D011687:Purines / Q000096:biosynthesis; D012265:Ribonucleotides / Q000378:metabolism; D014529:Uridine / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D007042:Hypoxanthines; D011687:Purines; D012265:Ribonucleotides; D010754:Phosphoribosyl Pyrophosphate; D000228:Adenine Phosphoribosyltransferase; D000248:Adenosine Kinase; D005947:Glucose; D000225:Adenine; D000241:Adenosine; D014529:Uridine